A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-28431754 in Type-2 Diabetes Mellitus Subjects Not Optimally Controlled (A1C >=7.0%) on Fixed Doses of Insulin therapy

Authors
Category Primary study
Year 2013
This article has no abstract
Epistemonikos ID: 0d32a1b1a90f17493f8f956474f30cec4c3753d5
First added on: Nov 09, 2018